Atara Biotherapeutics, Inc. (ATRA)

Atara Biotherapeutics Revenue

Atara Biotherapeutics had revenue of $40.19M in the quarter ending September 30, 2024, with 1,779.79% growth. This brings the company's revenue in the last twelve months to $100.44M, up 2,111.34% year-over-year. In the year 2023, Atara Biotherapeutics had annual revenue of $8.57M, down -86.51%.

• Revenue (ttm): $100.44M
• Revenue Growth: +2,111.34%
• P/S Ratio: 0.63
• Revenue / Employee: $446,396
• Employees: 225
• Market Cap: 60.60M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.57M	-55.00M	-86.51%
Dec 31, 2022	63.57M	43.23M	212.55%
Dec 31, 2021	20.34M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.